Cargando…
The role of CD38 in ischemia reperfusion injury in cardiopulmonary bypass and thoracic transplantation: a narrative review
BACKGROUND AND OBJECTIVE: Ischemia reperfusion injury (IRI) is often the underlying cause of endothelium breakdown and damage in cardiac or transplantation operations, which can lead to disastrous post-operative consequences. Recent studies of cluster of differentiation 38 (CD38) have identified its...
Autores principales: | Gouchoe, Doug A., Vijayakumar, Ammu, Aly, Ahmed H., Cui, Ervin Y., Essandoh, Michael, Gumina, Richard J., Black, Sylvester M., Whitson, Bryan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636473/ https://www.ncbi.nlm.nih.gov/pubmed/37969313 http://dx.doi.org/10.21037/jtd-23-725 |
Ejemplares similares
-
Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass
por: Veres, Gábor, et al.
Publicado: (2015) -
Deficiency of Interleukin-36 Receptor Protected Cardiomyocytes from Ischemia-Reperfusion Injury in Cardiopulmonary Bypass
por: Luo, Cheng, et al.
Publicado: (2020) -
Anti-oxidative or anti-inflammatory additives reduce ischemia/reperfusions injury in an animal model of cardiopulmonary bypass
por: Salameh, Aida, et al.
Publicado: (2020) -
Effects of inosine on reperfusion injury after cardiopulmonary bypass
por: Veres, Gábor, et al.
Publicado: (2010) -
Priming of Cardiopulmonary Bypass with Human Albumin Decreases Endothelial Dysfunction after Pulmonary Ischemia–Reperfusion in an Animal Model
por: Selim, Jean, et al.
Publicado: (2022)